Smith+Nephew Prepared to Capitalize on ASC Acceleration

By Mike Evers

Smith+Nephew Prepared to Capitalize on ASC Acceleration
The company's orthopedic sales fell -34% in 2Q20, but Smith+Nephew is strategically positioned to benefit from the acceleration in ASC procedures.

Member-Only Content

SUBSCRIBE Login

Product Labels: Hip Replacement, Robot-Assisted Systems

Tags: Revenue Report, Product Launch